Estimated annual direct medical costs of manifestations among patients with activated phosphoinositide 3-kinase delta syndrome
- DOI
- 10.1007/s10238-025-01773-1
- Published
- 2025-07-12
- Container
- Clinical and Experimental Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10238-025-01773-1,
title = {Estimated annual direct medical costs of manifestations among patients with activated phosphoinositide 3-kinase delta syndrome},
author = {Nicholas L. Hartog and Eveline Y. Wu and Nicholas L. Rider and Yang Meng and Brian Hartline and Philippe Adams and Saurabh Aggarwal and Amanda Harrington},
year = {2025},
journal = {Clinical and Experimental Medicine},
doi = {10.1007/s10238-025-01773-1},
url = {https://doi.org/10.1007/s10238-025-01773-1}
}RIS
TY - JOUR TI - Estimated annual direct medical costs of manifestations among patients with activated phosphoinositide 3-kinase delta syndrome AU - Nicholas L. Hartog AU - Eveline Y. Wu AU - Nicholas L. Rider AU - Yang Meng AU - Brian Hartline AU - Philippe Adams AU - Saurabh Aggarwal AU - Amanda Harrington PY - 2025 JO - Clinical and Experimental Medicine DO - 10.1007/s10238-025-01773-1 UR - https://doi.org/10.1007/s10238-025-01773-1 ER -
APA
Hartog, N. L., Wu, E. Y., Rider, N. L., Meng, Y., Hartline, B., Adams, P., Aggarwal, S., & Harrington, A. (2025). Estimated annual direct medical costs of manifestations among patients with activated phosphoinositide 3-kinase delta syndrome. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-025-01773-1
Source records
- crossref · retrieved 2026-09-27T00:19:30.368Z